Klingman & Associates’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$415K Buy
+4,804
New +$423K 0.02% 254
2026
Q2
– Sell
-2,420
Closed -$210K – 359
2026
Q1
$210K Sell
2,420
-185
-7% -$17.7K 0.01% 321
2025
Q4
$250K Buy
2,605
+75
+3% +$7.28K 0.01% 284
2025
Q3
$241K Buy
+2,530
New +$233K 0.01% 288
2016
Q4
– Sell
-1,362
Closed -$118K – 229
2016
Q3
$118K Hold
1,362
– – 0.04% 125
2016
Q2
$118K Hold
1,362
– – 0.04% 124
2016
Q1
$102K Sell
1,362
-25
-2% -$1.88K 0.04% 138
2015
Q4
$107K Hold
1,387
– – 0.04% 151
2015
Q3
$92K Hold
1,387
– – 0.04% 163
2015
Q2
$103K Hold
1,387
– – 0.04% 131
2015
Q1
$108K Buy
+1,387
New +$105K 0.04% 123

Other funds holding MDT

Klingman & Associates's MDT Position: Q3 2026 in Review

Klingman & Associates opened a new position in Medtronic (MDT) in Q3 2026: 4,804 shares worth $415K. The stake represents 0.02% of the portfolio and ranks #254 among its holdings. This is a return to the name: Klingman & Associates previously reported a position in MDT as recently as Q1 2026.

Klingman & Associates first reported a position in MDT in Q1 2015 and has held it in 11 quarters since. 644 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Klingman & Associates held 4,804 shares of Medtronic worth $415K as of Q3 2026.
  • Medtronic was a new Klingman & Associates position in Q3 2026.
  • Medtronic made up 0.02% of Klingman & Associates's portfolio in Q3 2026, its #254 holding.
  • Klingman & Associates first reported a position in Medtronic in Q1 2015 and has held it in 11 quarters since.
  • 644 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Klingman & Associates's 13F filing for Q3 2026, filed 20 Oct 2026.